Tvardi Therapeutics, Inc. (TVRD) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$6.24M2013: -$237.0K2014: -$18.07M2015: -$25.19M2016: -$58.40M2017: -$59.48M2018: -$77.38M2019: -$111.68M2020: $5.38M2021: -$89.08M2022: -$87.53M2023: -$121.50M2024: -$28.11M2025: -$26.75M-$26.75M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$26.75M+4.8%
2024-$28.11M+76.9%
2023-$121.50M-38.8%
2022-$87.53M+1.7%
2021-$89.08M-1754.3%
2020$5.38M+104.8%
2019-$111.68M-44.3%
2018-$77.38M-30.1%
2017-$59.48M-1.9%
2016-$58.40M-131.9%
2015-$25.19M-39.4%
2014-$18.07M-7525.3%
2013-$237.0K+96.2%
2012-$6.24M